Memantine and Impaired driving ability - a phase IV clinical study of FDA data

Summary:

Impaired driving ability is reported as a side effect among people who take Memantine (memantine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Symbicort, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Impaired driving ability when taking Memantine. It is created by eHealthMe based on reports of 10,128 people who have side effects when taking Memantine from the FDA, and is updated regularly.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

What is Impaired driving ability?

Impaired driving ability is found to be associated with 747 drugs and 929 conditions by eHealthMe. Check the latest studies of Impaired driving ability.

On Jul, 09, 2026

10,128 people reported to have side effects when taking Memantine.
Among them, 13 people (0.13%) have Impaired driving ability.

Could Memantine cause Impaired driving ability?

Among these 13 people:

How long have people been on Memantine when they have Impaired driving ability? *

What is the gender of people who have Impaired driving ability when taking Memantine? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Impaired driving ability when taking Memantine? *

What are other drugs people take besides Memantine? *

What are other side effects people have besides Impaired driving ability? *

Nodule (a growth of abnormal tissue): 6 people, 46.15%
Confusion: 6 people, 46.15%
Fall: 6 people, 46.15%
Oral Fungal Infection: 4 people, 30.77%
Nasopharyngitis (inflammation of the nasopharynx): 4 people, 30.77%
Injury: 4 people, 30.77%
Gait Disturbance: 4 people, 30.77%
Hand Fracture: 4 people, 30.77%
Speech Disorder: 3 people, 23.08%
Pain In Extremity: 3 people, 23.08%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 46.15%
Pain: 4 people, 30.77%
Hypersensitivity: 3 people, 23.08%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 23.08%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 15.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 15.38%
Memory Loss: 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Fatigue (feeling of tiredness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Memantine and have Impaired driving ability?

- Check whether Impaired driving ability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Memantine:

Memantine (10,266 reports)

Browse all side effects of Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impaired driving ability:

Impaired driving ability (747 drugs)

Browse all the conditions that are associated with Impaired driving ability:

Impaired driving ability (929 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on memantine (the active ingredients of Memantine) and Memantine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.